As of 2024-12-12, the EV/EBITDA ratio of OPKO Health Inc (OPK) is -13.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPK's latest enterprise value is 1,126.26 mil USD. OPK's TTM EBITDA according to its financial statements is -81.45 mil USD. Dividing these 2 quantities gives us the above OPK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 15.7x | 15.2x |
| Forward P/E multiples | 11.5x - 17.6x | 14.0x |
| Fair Price | (1.60) - (1.93) | (1.80) |
| Upside | -200.6% - -221.3% | -213.2% |
| Date | EV/EBITDA |
| 2024-12-04 | -13.58 |
| 2024-12-03 | -13.74 |
| 2024-12-02 | -13.32 |
| 2024-11-29 | -13.41 |
| 2024-11-27 | -13.74 |
| 2024-11-26 | -13.49 |
| 2024-11-25 | -14.08 |
| 2024-11-22 | -13.74 |
| 2024-11-21 | -13.58 |
| 2024-11-20 | -13.74 |
| 2024-11-19 | -14.08 |
| 2024-11-18 | -14.25 |
| 2024-11-15 | -14.25 |
| 2024-11-14 | -14.08 |
| 2024-11-13 | -13.91 |
| 2024-11-12 | -14.00 |
| 2024-11-11 | -13.66 |
| 2024-11-08 | -13.24 |
| 2024-11-07 | -12.65 |
| 2024-11-06 | -12.82 |
| 2024-11-05 | -12.74 |
| 2024-11-04 | -12.91 |
| 2024-11-01 | -13.16 |
| 2024-10-31 | -13.16 |
| 2024-10-30 | -13.24 |
| 2024-10-29 | -13.91 |
| 2024-10-28 | -13.07 |
| 2024-10-25 | -12.40 |
| 2024-10-24 | -12.24 |
| 2024-10-23 | -12.74 |
| 2024-10-22 | -12.74 |
| 2024-10-21 | -12.65 |
| 2024-10-18 | -12.82 |
| 2024-10-17 | -12.74 |
| 2024-10-16 | -12.99 |
| 2024-10-15 | -12.82 |
| 2024-10-14 | -12.82 |
| 2024-10-11 | -12.74 |
| 2024-10-10 | -12.82 |
| 2024-10-09 | -13.07 |
| 2024-10-08 | -12.82 |
| 2024-10-07 | -12.65 |
| 2024-10-04 | -12.99 |
| 2024-10-03 | -13.16 |
| 2024-10-02 | -13.24 |
| 2024-10-01 | -12.99 |
| 2024-09-30 | -12.99 |
| 2024-09-27 | -13.24 |
| 2024-09-26 | -12.99 |
| 2024-09-25 | -12.91 |